Analyst Conference Summaries

Biotechnology Investor Aids

Ionis Pharmaceuticals

Disclosure: I bought an initial very small lot of IONS on August 10, 2017 at $45.82 per share.

conference date: November 7, 2017 @ 8:30 AM Pacific Time


Q1 not available
August 8, 2017
Nov. 7, 2017

Ionis Pharmaceuticals (IONS) is a clinical-stage biotechnology company specializing in RNAi based therapies.

Ionis Pharmaceuticals web site

Ionis Pharmaceuticals investor relations



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2017 William P. Meyers